| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  ELSAN Elsan, a leading group of private hospitalization in France, now has more than 28,000 employees and 7,500 liberal doctors who exercise in the group's 212 establishments and centers. They support more than 4.8 million patients per year. Our mission: to offer each quality, innovative and human care. Our raison d'être: act for the health of all, at the heart of the territories. Health Establishments Type: | 86 | 101 |
 |  Otsuka Medical Devices Co., Ltd. Since its establishment in February 2011, Otsuka Medical Devices Co., Ltd. has focused on developing unique solutions that improve the health and well-being of patients whose medical needs and conditions cannot yet be fulfilled by existing treatment methods. To achieve our aspiration of becoming a pioneer in the medical device industry, we combine global R&D efforts with the technology and drug discovery know-how inherent within the Otsuka group’s heritage. Type: | 1 | 26 |
 | GAE Conseil Expert in the prevention of addictive practices in professional environments: advice, awareness, training ... G.A.E Conseil, the reference player in the prevention of addictive work practices. Founded in 2014, Gae Conseil is an independent consulting firm specializing in the prevention of addictive practices in professional environments (psychoactive products and behavioral addictions). Around the partners of the firm and managers of the various expertise centers (audit and advice center, training center, employee assistance center in difficulty), Gae Conseil teams support private and public companies of all sizes and all sectors of activity in primary, secondary and tertiary prevention in order to … Type: | 55 | 44 |
 |  SWAP Food Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of familiar ingredients. From preparation to performance, SWAP Filet can replace chicken on any menu, enabling chefs to recreate classic recipes for modern times. Originally founded in France in 2020, we rebranded from Umiami to SWAP in 2024 to convey how simple it is for consumers and chefs to swap protein. … Tags: FrenchTech120 FrenchTech2030 Type: | 40 | 95 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 10 | 5 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: | 30 | 63 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 36 |
 | Jolt Capital Scaling responsible deeptech companies Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between €10m and €50m. Jolt Capital generates returns for its investors by enabling mid-sized technology-rich companies with strong fundamentals to execute their growth strategies, in sectors that offer good exit potential across software and hardware alike (cybersecurity, sensors, photonics, industrial processes, new energy systems, applied AI, robotics...) In providing growth capital to our portfolio companies, we support their scaling in new markets, new capacities and new acquisitions, … Type: | 106 | 36 |
 | Founders Future Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Venture Capital, Private Equity, Co-Investment, Tech, IA, Impact, Europe, Early Stage, and Growth Type: | 96 | 22 |
 | DealPotential Data aggregator designed for investment professionals in private markets. DealPotential is a Swedish Ai, data & research company working on a global scale, offering the next generation of an Investment Intelligence platform that helps Venture Capital and Private Equity firms to find, analyze and evaluate Companies, Markets, and investments. Augmented Analytics - Get Actionable Insights Faster and Easier! We eat, breath and sleep data. It's in our DNA. We aggregate data from more than 21,000 sources with over 200,000 data points. But too much data can be overwhelming. We want to simplify advanced data and give you understandable information that … Type: | 11 | 18 |
 | Marsh We shape the future through our perspective, expertise and solutions, empowering our clients to thrive. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk and define more effective paths to the right outcome. We go beyond risk to rewards for our clients, our company, our colleagues, and the communities in which we serve. Marsh, a business of Marsh McLennan (NYSE: MMC), is the world’s top insurance broker and risk advisor. Marsh McLennan is a global leader in risk, strategy and people, advising clients in … Type: | 50 | 12 |
 | M&M Conseil Public Affairs - Institutional Relations M & Amp; M Council has specialized in the organization of institutional events and in public affairs council for more than 25 years. Closer to French and European institutions, we organize key meetings between public, private and institutional actors. Public affairs consultancy, institutional communication, Evenementiel, and public relations Type: | 111 | 10 |
 | IRDI Capital Investissement IRDI Capital Investissement is a trusted partner, investor of the innovation and the SME on the South West of France. Based in Toulouse, Montpellier and Bordeaux, the management company IRDI Capital Investissement support in capital the companies based in the South West at every stages of their development (initiation, risk capital, development capital / transmission) for an cumulative oustanding amount of 300 million of euros. Type: | 83 | 39 |
 | SISTAFUND We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With a target of €100 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments … Type: | 71 | 9 |
 | Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 12 | 41 |
 | Endpoints News The biopharma world is here Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the intersection of science, money and power in the world's most innovative industry, and are a part of the Financial Times' FT Specialist group. Biotechnology, News, Drug Development, and Pharmaceuticals Type: | 27 | 61 |
 | SOSV SOSV is a multi-stage, deep tech VC focused on planetary and human health SOSV is a global venture capital firm that operates early stage startup development programs. SOSV’s programs are focused on revolutionary deep technology that promises the betterment of humanity and the planet. The firm’s strategy is to invest in a small number of highly promising startups and use its deeply resourced programs to accelerate product development, acquire customers, and scale. SOSV companies consistently raise funding rounds led by top tier investors. SOSV joins seed, Series A, and later rounds while providing founders with ongoing support and community. As … Type: | 105 | 502 |
 | Index Ventures Index helps the most ambitious entrepreneurs turn bold ideas into global businesses. Index Ventures partners with exceptional entrepreneurs – those with unique insight who are intrinsically driven to make their vision a reality. We help them turn their bold ideas into global businesses, and through the companies they build, have a long-lasting and positive impact on the world around us. Index-backed businesses are supported by an experienced team of investors, strategists, and an extensive global network built over three decades of startup investing. Working side-by-side through the scale up journey, we forge deep and long-lasting relationships with founders and their … | 29 | 111 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 11 | 13 |
 | Harlay Avocats #tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, … | 8 | 39 |
 | LimFlow Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 25 |
 | Elicit Plant Elicit Plan pioneers phytosterol-based solutions to strengthen crop resilience and boost yields amid climate hazards. ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit … Tags: FrenchTech2030 Type: | 22 | 75 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first plant-microbiome systems bioengineered to purify indoor air. Type: | 15 | 39 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 88 | 118 |
 | BionomeeX BionomeeX provides innovative analysis tools to support your biological, medical and environmental R&D projects. BionomeeX is a CNRS, and Univ. Montpellier spin off company. Our solutions include, at the same time, crafted algorithms and/or adapted computational solutions in a single package following your needs and demands. We also deploy our own software initially brewed in the academic world to provide solutions in biology, genetics, genomics... Biology, AI, and DeepLearning Type: | 14 | 6 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 38 | 7 |
 | PE Cube You're Good, get Better. PE Cube is a SaaS solution for each team member of Private Equity management companies to optimize fund management’s performance and Investor Relation while enabling a rich, reliable and transparent communication towards each of its stakeholders. PE Cube is based on 20 years of Private Equity practice and on the key-belief that data is crucial to each level of fund management. This is why PECube is designed to ensure flawless end-to-end processing to express the full potential for monitoring and steering fund management activity. Each general partner member is thus equipped to ensure reliability, security and … Type: | 42 | 10 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 79 | 20 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 26 | 64 |
 | HighLife Trans-septal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 5 | 73 |
 | GLEAMER Medical-Grade AI for Radiology GLEAMER offers a suite of AI solutions for radiology that encapsulate medical-grade expertise. Our company wants to support imaging readers to secure diagnoses for all patients at all times while improving comfort and workflow efficiency. Our team imagines and develops solutions booth at the level of an expert and is easy to integrate thanks to the joint work of a multi-disciplinary team encapsulating AI and radiologist experts. GLEAMER has already been integrated into more than 2.000 institutions in each part of the world. 🏅Alexander Margulis award - Scientific excellence for the BoneView clinical study 🏅 🏅 … Type: | 28 | 95 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 129 |
 | AngelNews News and comment from the world of angel investing AngelNews is a leading news service for the early-stage investment market including angel investors, venture capitalists, equity crowdfunding and entrepreneurs. Our aim is to encourage successful business by understanding the needs of our customers and offering bespoke services and packages to meet those needs. At present all of our publications and registration to our website is completely free of charge. Companies looking for funding also come to us to advertise their investment opportunities to our network of investors. With over 10,000 business angels and venture capitalists in our community, we have … Type: | 55 | 3 |
 | Form the Future CIC We help young people find their route through education into employment, and provide employers access to future talent We connect young people to a world of career possibilities, inspire them to dream big and empower them to fulfil their potential. We want to equip young people with the experience and skills they will need to succeed in their career of choice, and enable businesses to recruit skilled workers locally. We bridge the gap between these two worlds and help them work together and achieve more. We deliver the skills service for the Greater Cambridge Partnership, linking schools and businesses to … Type: | 28 | 35 |
 | Portugal Digital Moving Forward Moving With a Purpose Portugal Digital is the country's transformation engine. Its purpose is to accelerate Portugal, without leaving anyone behind, and to highlight this mission in the world. How? Through the digital empowerment of people, the digital transformation of businesses and the digitalization of the Public Administration. Type: | 13 | 1 |
 | Tigem Telethon Institute of Genetics and Medicine TIGEM is a multidisciplinary research Institute devoted to the study of the mechanisms underlying rare genetic diseases and to the development of new therapies. The institute is one of the most important centers for fundamental life science research in Italy (https://www.tigem.it/). It is particularly renowned for its research on diseases such as lysosomal disorders, membrane trafficking defects, disorders of liver metabolism, and eye diseases. The unique funding environment of TIGEM forges important critical mass and facilitates opportunities to conduct both long-term and high-impact science that would otherwise be difficult to undertake. TIGEM is a … Type: | 1 | 315 |
 | SynBioBeta Synthetic Biology Events & Industry Information 🧬 SynBioBeta is the premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet. We provide our community members with personal and professional development support, as well as valuable opportunities for networking, partnership, collaboration, and education. Every year we host The Global Synthetic Biology Conference which showcases the cutting-edge developments in biology that are transforming how we fuel, heal, and feed the world. In addition, we stage a variety of other conferences, thought leader retreats, and local meet-ups throughout the … Type: | 56 | 26 |
 | Novozymes Novozymes has combined with Chr. Hansen to become Novonesis: linkedin.com/company/novonesis. This global biosolutions company of 10,000 people is transforming how the world produces, consumes and lives. In 30-plus industries, its biosolutions help businesses meet their needs and the needs of our planet. Novozymes was formed in 2000 when Novo Nordisk split into three companies: Novo Nordisk A/S, Novozymes A/S and Novo A/S. Novozymes was the world leader in biological solutions with a commitment to Rethink Tomorrow. It served 130 markets with enzymatic, microbial and advanced protein solutions. The company’s solutions enabled higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel … Type: | 28 | 9,570 |
 | iii - financements Non -dilutive financing levers Advice and expertise in non-dilutive funds (public and private funding): innovation, investment, international. Implementation in Paris, Nantes, Lyon, Bordeaux, Rouen, Marseille and Lille. Each year, more than 1,000 new businesses trust us with just as many customers who rely on us. We work on the long term with each company, because the overall funding strategy must be built over time. Help innovation, international aid, search for public funding, tax optimization, banking funding, international, Impacts, and calls for projects Type: | 76 | 121 |
 | Sky News The full story, first, from the heart of the events changing our world. At Sky News, our mission is to give you the full story, first, wherever you get your news. Because when you’ve got the full story, you can make up your own mind. We believe this has never mattered more. We give you the full story, first by: Taking you there, 24:7. So you can see what’s really happening. Asking the big questions. So you can find out what matters. Through bold and independent reporting. Giving you a fresh perspective. Type: | 84 | 969 |
 | CNBC Welcome to CNBC's home on LinkedIn! Follow us for regular updates about financial news, top CNBC.com stories, behind-the-scenes moments and more. CNBC, Inc. provides business news in the United States and Canada. It provides real-time financial market coverage and business information. The company, through its Web site, cnbc.com, provides real-time market analysis; video programming daily; industry and topic-specific blogs; cnbc.com live stream, a long-form scheduled programming of events; charts; and investing tools. The company was founded in 1989 and is headquartered in Englewood Cliffs, New Jersey. CNBC, Inc. operates as a subsidiary of NBC Universal, Inc. Financial News, Stocks, Market … Type: | 373 | 3,054 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 18 |
 | Acteurs de La French Care The grouping of actors who support and develop the health ecosystem in France! The grouping of actors who support and develop the health ecosystem in France! Type: | 43 | 1 |
 | COMET Manufacturer of Arrabina® –– Nature's Best Dietary Fiber, Perfected COMET is an award-winning food ingredients company based in London, Ontario, and Schaumburg, Illinois. COMET's proprietary line of Arrabina dietary fibers are upcycled certified and can easily be added to any food and beverage application. sustainability, dietary fiber, prebiotics, sugar reduction, food technology, food ingredients, upcycling, gut health, digestive health, gut microbiome, food innovation, and upcycling Type: | 11 | 21 |
 | Merieux Equity Partners Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and … Type: | 15 | 39 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 44 | 170 |
 | MaaT Pharma Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed … Type: | 36 | 88 |
 | Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 17 | 82 |
 | BioLabs Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical Type: | 50 | 9 |
 | Sightline Climate (CTVC) Bringing clarity to the new climate economy Sightline Climate is the market intelligence platform bringing clarity to the new climate economy. Built on the foundation of the CTVC newsletter, Sightline Climate’s subscription intelligence product provides data, tools, and frameworks to help investors, corporates, and governments build and finance the new climate economy. Explore Sightline Climate: https://www.sightlineclimate.com/ CTVC is the industry-leading free newsletter powered by Sightline Climate. Join the community of 60,000 climate leaders. Subscribe: https://www.ctvc.co/ Type: | 83 | 41 |
 | Clarivate Think forwardTM ClarivateTM is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com. Scientific and academic research, patent analytics and regulatory standards, pharmaceutical and biotech intelligence, trademark protection, domain brand protection, intellectual property management., Life science research, Patent analytics, Regulatory Standards, Technology, Trademark Research, IP and Standards, Intellectual Property Management, Anti-Fraud, Brand Protection, Anti-Piracy, Proprietary Software, Data analytics, Predictive data, Clinical Trial Research, and Competitive Intelligence Type: | 78 | 10,650 |
 | Mauna Kea Technologies The real-time in vivo cellular imaging platform that revolutionizes the way physicians diagnose and treat patients. Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative … Type: | 20 | 125 |
 | MGA Technologies Innovation, instruments, machines sur mesure et solutions digitales pour l'industrie du futur Our mission: design, develop and manufacture custom-made machines, innovative equipment and product lines for industries of the future. Our competencies: design, 3D CAD, automatisation and supvervision, robotics integration, clean room integration, numeric axis, marking, datamatrix, RFID, vision and controls.... References: Sanofi, Fresenius Medical Care, Boehringer Ingelheim, bioMérieux, L'Oréal, Valéo, Michelin, Schneider Electric, Becton Dickinson, ST Microelectronics, Staubli, ITEN, Buashc+Lomb, Xfab, EFI Automotive, STILLA, Soitec, Ceva, Symatese Device, Bobst, IPSEN, Medtronic, ABL Europe, Catalent, Pfizer, Clariant, Aguettant, Service de Santé des Armées... Robotics integration, Sterile flexible welders, Automated assembly … Type: | 59 | 102 |
 | NextGen IT (IMA) The circle of decision -makers of French ISDs, extension of the IMA focused on the challenges of transformation of the IT The Next-Gen IT circle brings together IT/DSI/CYBER decision-makers from 130 adherent organizations of the IMA on the subjects of evolution of IT and cybersecurity technologies, in order to share good practices and recommendations, confront experiences and reflections, and accelerate its projects. _ Extension of the IMA (www.ima-dt.org - main French -speaking consortium in technological directions - 130 members including 3/4 of the CAC40) specifically focused on the evolution and transformation of IT and cybersecurity, the circle "Next Gen it" … Type: | 94 | 20 |
 | Purespring Therapeutics We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases Type: | 1 | 56 |
 | Venionaire DealMatrix Transactions Made Easy. DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching | 48 | 7 |
 | Biotalys Transforming crop protection We are an agricultural technology (agtech) company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of crop protection products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to have … Type: | 11 | 69 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 3 | 253 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 3 | 34 |
 | Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 8 | 130 |
 | Chromologics Natural Colors Crafted By Fermentation Chromologics is a Danish biotech start-up responding to the strong market pull for novel natural food colorants. We develop fungal fermentation solutions for the production of natural pigments. Our proprietary production process allows not only for a more sustainable production than existing solutions, but is also cost-competitive. Our pigments are produced by a non-GMO fungus, which makes them compliant with the dietary requirements of broad consumer bases such as kosher, halal, and vegan diets. Fermentation, Natural Colorants, University Spin-Out, Downstream Processing, and Color formulation Type: | 5 | 26 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: | 4 | 181 |
 | Cure51 We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus … Type: | 7 | 39 |
 | Cyber Valley Europe’s largest and leading center for excellence in artificial intelligence and modern robotics. Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber … Type: | 13 | 28 |
 | Intermediate Capital Group (ICG) Global alternative asset manager, creating sustainable value by partnering with ambitious businesses. We are a global alternative asset manager with a 35-year track record. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Private Markets, Private Capital, Alternative Asset Management, Private Credit, Private Debt, Secondaries, Structured Products, Real Assets, Infrastructure, Real Estate, and Life Sciences Type: | 13 | 797 |
 | Apollo Global Management, Inc. Apollo is a high-growth alternative asset manager. Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions … Type: | 24 | 4,435 |
 | STAT Reporting from the frontiers of health and medicine. Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and … Type: | 46 | 361 |
 | Northzone Northzone is a venture capital fund shaped by lives as entrepreneurs and investors. Founded in 1996. Northzone is a technology investment partnership. With two decades of experience, we have been chosen by some of the best entrepreneurs as their long-term partner for growth. With offices across the Nordics, London and in New York, we work around the clock to connect our companies with customers, business partners and key talent on a truly international scale. As former entrepreneurs ourselves, we have been sat on both sides of the table, and place the relationships with our Founders at the core of our … Type: | 57 | 61 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 12 | 1,394 |
 | MATWIN French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de … Type: | 74 | 6 |
 | BIOWEG Revolutionizing the Future of Bio-ingredients BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign. We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients. Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals. We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies. Material Science, Fermentation , Green Chemistry, Alternative Ingredients, Biobased Materials, Biodegradabe, … Type: | 29 | 16 |
 | Prassack Advisors, LLC Global, independent, strategic management consultancy - Food, feed, fuel & fibre Prassack Advisors provides strategic advice and ongoing intelligence for clients in the global agriculture, food, water and energy sectors. By helping established and emerging innovators we deliver solutions that matter for farmers, agribusiness and food producers. Our experienced team employs a unique research approach which combines a focus on primary research and our extensive “ground truthing” network to deliver actionable insights, connections and competitive advantage to our clients. For more information, please visit our website at www.prassackadvisors.com. Or reach out directly via email to info@prassackadvisors.com or call 1-720-675-9456. Innovation … Type: | 20 | 3 |
 | RE:CHEMISTRY - By GFBio We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products. We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products by replacing harmful petro-based ingredients. Levulinic Acid, Application Development, R&D, Green Chemistry, and Formulation Development Type: | 6 | 35 |
 | May Health We are bringing a modern approach to the treatment of PCOS with our investigational Ovarian Rebalancing Treatment. May Health, formerly AblaCare, is developing a modern approach to PCOS. Type: | 3 | 27 |
 | SpineGuard Securing Implant Placement Making Spine Surgery Safer SpineGuard is a French innovative medical company dedicated to the deployment and adoption of DSG® (Dynamic Surgical Guidance), powerful radiation-free real time sensing technology platform that spans a broad spectrum of skeletal applications from bone drilling instruments to automated placement of bone implants. Uniquely positioned to change the game in orthopedic robotic surgery. Devices, built with the DSG technology, give real-time audio and visual feedback to the surgeons to secure and streamline skeletal implant placement for the benefit of patients, surgeons, operating room staff and healthcare providers. The PediGuard probes are the only … Type: | 2 | 30 |
 | Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design Type: | 7 | 72 |
 | ClimateHack ClimateHack is where impact-driven Founders and Funders come to meet, learn and build together. Join us at a ClimateHack Meetup to connect with your local community. Subscribe to ClimateHack weekly to stay ahead of the curve on the latest funding, partnerships and news in ClimateTech. Type: | 40 | 28 |
 | Italian Tech Alliance Already VC Hub Italia is the association of venture capital, innovative investors, startups and innovative SMEs Italian Tech Alliance is the reference association for: - venture capital funds; - Investors in innovation; - Startups and innovative SMEs. The objective of the Association is to promote the development of the ecosystem of technology and innovation in Italy, working closely with the institutions. The contents of Italian Tech Alliance spread interesting news, opportunities and reports for the private and public stakeholders that work for the country's economic and social growth. They currently sit on the Board of Directors: Alessio Beverina - Secretary … Type: | 12 | 14 |
 | HarperCollins Publishers Publishing great authors since 1817. HarperCollins Publishers is the second-largest consumer book publisher in the world. Headquartered in New York, HarperCollins has publishing operations in 15 countries. With two hundred years of history and more than 120 branded imprints around the world, HarperCollins publishes approximately 10,000 new books every year in 16 languages, and has a print and digital catalog of more than 200,000 titles. Writing across dozens of genres, HarperCollins authors include winners of the Nobel Prize, the Pulitzer Prize, the National Book Award, the Newbery and Caldecott Medals, and the Man Booker Prize. HarperCollins is a subsidiary of … Type: | 33 | 4,286 |
 | The Wall Street Journal Winner of 37 Pulitzer Prizes for outstanding journalism, The Wall Street Journal includes coverage of U.S. and world news, politics, arts, culture, lifestyle, sports, health and more. It's a critical resource of curated content in print, online and mobile apps, complete with breaking news streams, interactive features, video, online columns and blogs. Since 1889, readers have trusted the Journal for accurate, objective information to fuel their decisions as well as enlighten, educate and inspire them. On LinkedIn, we will share articles to help you navigate your career, including stories from our business, management, leisure and technology sections. Subscribe: http://on.wsj.com/1n1uvCH Job … Type: | 262 | 11,695 |
 | NatureWorks A naturally advanced biomaterials company using plants to turn greenhouse gases into IngeoTM️ PLA biopolymers. NatureWorks is an advanced materials company offering a broad portfolio of renewably-sourced polymers and chemicals to the packaging, polymers, fibers, and chemicals markets. With performance and economics that compete with oil-based plastics and fibers, naturally advanced IngeoTM polymers are valued for their unique functional properties and used in products from coffee capsules and electronics to diapers and wipes. Creating performance through chemistry, VercetTM lactide-based solutions help innovators realize significant, measurable performance and cost advantages in products such as C.A.S.E., toners, and surfactants. NatureWorks is jointly … Type: | 14 | 217 |
 | Marks & Clerk Leading global network of intellectual property specialists We’re true specialists – focusing on IP and IP alone. With patent attorneys, trade mark attorneys, commercial lawyers and IP litigators, we can provide every type of intellectual property service you need. Our expertise is globally acknowledged - in our top tier status, the awards we’ve won and in the cutting-edge work we do, which helps shape future law. Intellectual property, Litigation, Prosecution, Patents, Trade Marks, Law, Designs, Copyright, Unified Patent Court, and EPO | 8 | 626 |
 | INSIDE We read all of the business news so you don’t have to. Subscribe today. Executive briefings of the news you need. Join the waitlist for product launch mid-2024: https://docs.google.com/forms/d/e/1FAIpQLSeF3zupwgUiJ90O2dy5IXdCb6ZaYT28w7JCgpcUMi5z912tvA/viewform Founder: Jason Calacanis Jason Calacanis co-founded and was the CEO of Weblogs, Inc., a network of popular weblogs that was sold to AOL in November 2005. Upon joining AOL, he was appointed senior vice president. In addition, he was named general manager of AOL’s Netscape and was responsible for the July 2006 relaunch of the iconic browser as a social bookmarking news site. Investors include: Sequoia Capital, CBS, Elon Musk, Matt … Type: | 94 | 28 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models Type: | 15 | 27 |
 | CONCILIO Your key to better care. CONCILIO is revolutionizing healthcare access with its unique MEDICAL CONCIERGE service, which combines cutting-edge technology with a team fully dedicated to the well-being of employees and their families. We support businesses and their employees daily through a wide range of services: doctor recommendations, easy appointment scheduling, teleconsultations, digital health assessments, and preventive programs. Concilio also offers its partners the chance to benefit from its advanced technological expertise through CONCILIO SOLUTIONS. This service enables professionals to innovate, increase profitability, and leverage our proven technologies, teams, and processes. E-santé, Téléconsultation, Recherche de Médecins, Bilan Santé, téléconseil médical, … Type: | 26 | 43 |
 | EKTAH New nutritional solutions to reduce human and animal body weight gain Ektah's mission is to give pleasure to each individual in a situation of obesity or overweight allowing him to reduce his body weight and find a healthy, tasty and balanced diet without depriving himself. The scientific approach to society consists in identifying lipid "lures (or agonists)" capable of activating or-gustative receptors, more intensely than food acids, thus allowing the brain to trigger early satiety, which will immediately lead to a reduction in food intake. These lures do not bring calories and also trigger more intense food pleasure than that … | 26 | 3 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 11 | 35 |
 | RebrAIn ReBrain standardizes targeting for DBS and brain lesion surgeries in Parkinson and essential tremor diseases RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated. Type: | 28 | 18 |
 | Catsalyze We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze. Type: | 31 | 3 |
 | VERTEXA Digital Therapeutics Vertexa is an immersive therapeutic game, in virtual reality. Digitalize health! Green Digital Therapy (Virtual Reality Therapy Exhibition in Anorexia) aims to use virtual reality as a support tool in the form of a lodified and immersive psychoeducative course in patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies today allow an innovative, personalized, motivating and accessible approach regardless of the place of care of our patients. The Vertexa tool aims to be autonomous: the patient is an actor in his management. It will be immersed in a soothing universe, accompanied by a traveling … Type: | 23 | 2 |
 | Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory Type: | 1 | 19 |
 | AudioTelligence Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their … Type: | 19 | 8 |
 | GOURMEY 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. [join.gourmey.com] GOURMEY is France's pioneering cultivated meat company. 🌎 We create sustainable cultivated meat delights for an uncompromising and conscious generation. > Join.gourmey.com Type: | 37 | 107 |
 | datacraft The Data Scientists Club Datacraft allows an exchange of good practices between data experts. It is a unique club model, inspired by companionship, and imagined to allow data scientists / data engineers to train between peers and allow companies to accelerate their IA / data projects Access to the club is through annual membership. Type: | 77 | 19 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 13 |
 | Johns Hopkins Technology Ventures (JHTV) Bringing the benefits of academic discovery to the world. Johns Hopkins Technology Ventures advances innovation ecosystems and develops tomorrow's solutions for today's biggest challenges. Our mission is to maximize the impact of Johns Hopkins University’s research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products, and services that benefit society. Diagnostics, Therapeutics, Medical Devices, Research Tools, Imaging, Healthcare IT, Engineering, Robotics, Digital Innovation, Digital Health, Precision Medicine, Materials Science, Oncology, Ophthalmology, Drug Discovery, Neurology, Commercialization, and Technology Transfer Type: | 18 | 157 |
 | Silicon Valley Bank Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world’s most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens Bancshares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn … Type: | 153 | 1,860 |
 | Forum Ventures Investing in and supporting the B2B SaaS journey from Zero to One Forum Ventures is the leading early-stage fund, program and community for B2B SaaS startups. Founded in 2014 as Acceleprise, we’re on a mission to make the B2B SaaS journey easier, more accessible and successful for early-stage founders, through funding, high touch programming, corporate perks and introductions, and an active SaaS community. Forum For Founders, our pre-seed program, provides founders with $100k in funding and 15 intense weeks of talks, events, mentorship and 1:1 guidance focused on go to market and fundraising. Forum Seed, our seed fund, backs exceptional … Type: | 24 | 121 |
 | Panakes Partners Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our … Type: | 17 | 17 |
 | La Gazette du Midi Follow all the economic news of Toulouse and Haute-Garonne in an instant. The Gazette du Midi is a weekly economic and legal information whose headquarters are in Toulouse. Created in 1881, the newspaper was authorized for the publication of judicial and legal announcements in Haute-Garonne. He is part of the Forumeco group. Type: | 120 | 12 |
Media